Kolon TissueGene, Inc.

Quick facts

Phase 3 pipeline

• Sham Control
  Sham Control is a placebo comparator used in clinical trials and does not exert any pharmacological effect.
• TG-C · Orthopedics / Regenerative Medicine
  TG-C is a gene therapy that delivers TGF-β3 to cartilage tissue to promote cartilage regeneration and repair.
• TissueGene-C · Liver disease
  TissueGene-C is a gene therapy that uses a viral vector to deliver the human hepatocyte growth factor (HGF) gene to the liver, promoting tissue repair and regeneration.

Phase 1 pipeline

• TG-C High Dose
• TG-C Low Dose
• TG-C Mid Dose

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kolon TissueGene, Inc. portfolio CI brief
• Kolon TissueGene, Inc. pipeline updates RSS